Visa

Mizuho analyst Dan Dolev maintains Visa with a Neutral and maintains $265 price target.

Wells Fargo analyst Donald Fandetti maintains Visa with a Overweight and raises the price target from $300 to $325.

Oppenheimer analyst Dominick Gabriele reiterated the Outperform rating on Visa Inc. (NYSE:V), with a price target of $297. Per the analyst, the company’s cash and check opportunity remains vast. Value-added-service (VAS) growth is likely to remain robust, while weakness in new flow growth in 1Q24 was largely due to one-time items and grow-over impacts, the analyst adds. VAS is expected to grow above the consumer payments growth rate, and the total VAS growth spread is expected to be between open banking, risk, and advisory. Overall, Gabriele highlights Visa’s powerful brand, vast global acceptance network, and strong business model. According to the analyst, the company is well-positioned to benefit from the long-term secular shift from paper currency (cash/check) to plastic (electronic payments), consumer spending growth, and increased globalization. The company has a strong franchise in the US and garners an increasing proportion of growth from international markets, noted the analyst. He adds that Visa

Visa Inc. (NYSE:V) Stock Analyst Ratings Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/29/2024 16.39% Barclays $304 → $319 Maintains Overweight 01/26/2024 18.94% Susquehanna $300 → $326 Maintains Positive 01/26/2024 14.93% UBS $305 → $315 Maintains Buy 01/26/2024 12.74% RBC Capital $290 → $309 Maintains Outperform 01/26/2024 14.93% Keefe, Bruyette & Woods $305 → $315 Maintains Outperform 01/26/2024 2.16% Wedbush $270 → $280 Maintains Outperform 01/26/2024 13.47% Raymond James $287 → $311 Maintains Outperform 01/18/2024 -3.31% Mizuho $243 → $265 Maintains Neutral 01/08/2024 9.46% Keybanc $275 → $300 Maintains Overweight 12/20/2023 — Monness, Crespi, Hardt Initiates Coverage On → Neutral 12/14/2023 11.28% UBS $295 → $305 Maintains Buy 12/12/2023 7.63% Jefferies $280 → $295 Maintains Buy 12/05/2023 2.16% BMO Capital → $280 Initiates Coverage On → Outperform 10/31/2023 -11.34% Mizuho $240 → $243 Maintains Neutral 10/30/2023 1.43% Barclays $285 → $278 Maintains Overweight 10/25/2023

Barclays analyst Raimo Lenschow maintains Visa (NYSE:V) with a Overweight and raises the price target from $304 to $319.

Visa’s persistent growth continues to be underestimated by Wall Street, UBS analysts say in a research note. The digital payments company has attractive qualities in the current environment and could grow through moderate recessionary conditions, analysts say. The company also has high-quality EPS and margins. Still, investors are concerned about cash to card conversion slowing, as well as on U.S. online debit routing, creating an attractive buying opportunity, analysts add. Shares fall 1.4% to $268.93.

Visa’s (V) earnings could benefit from the ongoing strength of international travel, Morgan Stanley said Friday in a note. The investment firm’s expectations are based on management’s commentary on healthy travel volumes in Latin America, Europe, Central Europe, Middle East, and Africa and the US. Visa’s international volumes showed healthy growth while US domestic spending witnessed a slowdown due to various transient factors, including a less favorable mix of weekends, softer performance in October and impacts from debit card regulations, the brokerage firm said. Morgan Stanley revised the price target on V’s stock to $318 from $292 and reiterated overweight rating.

Visa is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. It reported fourth-quarter adjusted earnings of $2.41 a share on Thursday, while analysts surveyed by FactSet had expected $2.34. Visa also said U.S. payment volume growth slowed in January amid extreme weather conditions. Raymond James, RBC Capital and UBS raised Visa price targets on Friday. Shares were recently down 1.6%. Dow Jones & Co. owns Factiva.